Replies to post #373735 on Anavex Life Sciences Corp (AVXL)

[ignatiusrielly35]

I understand your proposed share buyback strategy. It just seems to me to be risky, akin to trading your own shares by trying to time the market. With no revenue, unless a clinical biotech company has a serious overstock of cash, I don’t think any sane CEO would ever attempt this strategy.